🟢 IDEXX is trading 4.3% up in pre-market after Q3 beat and 2026 guidance hike

IDEXX is trading $574.70 (+4.26%) in pre-market on November 2 after third-quarter results beat analyst expectations.

• Revenue was $1.21 billion and reported earnings were $4.01 per share, versus the $1.19 billion and $3.71 per share expected by six analysts surveyed by Zacks.
• Management raised 2026 revenue guidance to $4.741–$4.767 billion and EPS guidance to $14.96–$15.16; strong recurring diagnostics revenue helped support the revised outlook.